Kidder Stephen W Has $292,000 Holdings in Walgreens Boots Alliance Inc (NASDAQ:WBA)

Kidder Stephen W reduced its position in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 16.5% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 5,350 shares of the pharmacy operator’s stock after selling 1,058 shares during the period. Kidder Stephen W’s holdings in Walgreens Boots Alliance were worth $292,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Nelson Roberts Investment Advisors LLC acquired a new position in shares of Walgreens Boots Alliance during the 1st quarter valued at about $25,000. Meridian Wealth Management LLC acquired a new position in shares of Walgreens Boots Alliance during the 1st quarter valued at about $25,000. Horan Capital Advisors LLC. acquired a new position in shares of Walgreens Boots Alliance during the 1st quarter valued at about $25,000. Trustcore Financial Services LLC bought a new stake in Walgreens Boots Alliance during the 1st quarter valued at approximately $31,000. Finally, Sageworth Trust Co bought a new stake in Walgreens Boots Alliance during the 2nd quarter valued at approximately $27,000. 62.19% of the stock is currently owned by institutional investors and hedge funds.

Shares of WBA stock traded down $0.39 during mid-day trading on Friday, reaching $53.68. The stock had a trading volume of 4,519,894 shares, compared to its average volume of 4,236,000. The company has a 50 day moving average of $54.37. The company has a current ratio of 0.76, a quick ratio of 0.37 and a debt-to-equity ratio of 0.49. Walgreens Boots Alliance Inc has a one year low of $49.31 and a one year high of $86.31. The company has a market capitalization of $48.83 billion, a price-to-earnings ratio of 8.94, a PEG ratio of 1.35 and a beta of 0.81.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings data on Thursday, June 27th. The pharmacy operator reported $1.47 EPS for the quarter, topping the Zacks’ consensus estimate of $1.42 by $0.05. Walgreens Boots Alliance had a return on equity of 22.08% and a net margin of 3.53%. The company had revenue of $34.59 billion during the quarter, compared to the consensus estimate of $34.52 billion. During the same quarter last year, the company earned $1.53 EPS. The company’s quarterly revenue was up .7% on a year-over-year basis. As a group, sell-side analysts expect that Walgreens Boots Alliance Inc will post 5.99 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, September 12th. Shareholders of record on Tuesday, August 20th will be given a $0.458 dividend. The ex-dividend date is Monday, August 19th. This represents a $1.83 dividend on an annualized basis and a dividend yield of 3.41%. This is an increase from Walgreens Boots Alliance’s previous quarterly dividend of $0.44. Walgreens Boots Alliance’s dividend payout ratio (DPR) is currently 29.24%.

Several analysts recently weighed in on the company. Guggenheim assumed coverage on Walgreens Boots Alliance in a research note on Thursday, April 18th. They set a “neutral” rating and a $59.00 target price for the company. Zacks Investment Research downgraded Walgreens Boots Alliance from a “hold” rating to a “sell” rating and set a $53.00 target price for the company. in a research note on Monday, June 10th. ValuEngine upgraded Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research note on Friday, June 28th. BidaskClub downgraded Walgreens Boots Alliance from a “sell” rating to a “strong sell” rating in a research note on Monday, June 24th. Finally, Bank of America decreased their target price on Walgreens Boots Alliance from $53.00 to $51.00 and set an “underperform” rating for the company in a research note on Monday, June 3rd. Six research analysts have rated the stock with a sell rating, ten have issued a hold rating and four have given a buy rating to the stock. The stock has an average rating of “Hold” and an average target price of $63.82.

In other Walgreens Boots Alliance news, CAO Marco Patrick Anthony Pagni sold 20,000 shares of the firm’s stock in a transaction that occurred on Thursday, May 9th. The stock was sold at an average price of $53.05, for a total value of $1,061,000.00. Following the completion of the sale, the chief accounting officer now owns 435,811 shares in the company, valued at approximately $23,119,773.55. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 15.73% of the stock is currently owned by company insiders.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.

Featured Article: Moving Average Convergence Divergence (MACD)

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.